Financial analysis
Download
1 / 8

Financial Analysis - PowerPoint PPT Presentation


  • 87 Views
  • Uploaded on

Financial Analysis. Growth Drivers Global Sales Growth Product Growth Structure Increase of Cash Flow Risky structure. Global Sales Growth. EMEA Expansion on generic utilization 360 New Products APAC Expansion of Products 50 New Products Japan well positioned for future growth

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Financial Analysis' - lesley


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Financial analysis
Financial Analysis

  • Growth Drivers

    • Global Sales Growth

    • Product Growth

  • Structure

    • Increase of Cash Flow

    • Risky structure


Global sales growth
Global Sales Growth

  • EMEA

    • Expansion on generic utilization

    • 360 New Products

  • APAC

    • Expansion of Products

    • 50 New Products

    • Japan well positioned for future growth

    • India and China-Emerging Market expansion

  • North America

    • Expansion of Products

    • 90 New Products

    • 500 New Products through year 2013


  • Product growth
    Product Growth

    • EpiPen Auto-Injector

      • Expansion in Markets (Europe)

      • Three 10% price increases

  • COPD Treatment

    • Introduction of products

    • Launch for 2015

    • Potential for $500 million peak sales

  • Biogenerics

    • Launch in US 2014

    • Launch in less regulated Markets 2013

  • Generic Copanxone

    • Expansion into Emerging Markets


  • Mylan s financial structure
    Mylan’s Financial Structure

    • Risky

      • Cash Coverage Ratio

        • Low from 2010 to 2014

        • Financially risky

      • Debt Equity Ratio

        • More debt then equity

        • Compared to industry ranked 11

  • Cash Flow

    • Increase with product and market expansion

    • OCF increase from 2011 to 2013

    • Reduce debt and create more value.


  • Generic investor s valuation
    Generic Investor’s Valuation

    • DCF vs. Economic Profit

    • Expected Value Analysis

      • Key Driver Operating Margin



    Expected value analysis
    Expected Value Analysis

    • Key Driver

      • Operating Margin


    Why operating margin
    Why Operating Margin?

    • Largest affect on value

    • Factors that impact OM

      • Increase Unit Price of Product

      • Expand Product Line

      • Expand Geographical Reach

    • Equity Value Increase to $26.48


    ad